In 2015, Ainuddin et al. designed an open-labeled RCT to compare the therapeutic indexes among metformin alone, insulin alone and their combined use (when metformin alone did not achieve glucose targets) in 150 women with GDM [56]. This evidence concerns the gene INS and gestational diabetes.